Evaluation of SAMBA II: A Qualitative and Semiquantitative HIV Point-of-Care Nucleic Acid Test.

Lauren R VioletteAndy Cornelius-HudsonMadison SnidarichLisa A NiemannSonny Michael AssennatoAllyson RitchieNeha GoelPollyanna R ChavezSteven F EthridgeDavid A KatzHelen LeeKevin P DelaneyJoanne D Stekler

Published in: Journal of acquired immune deficiency syndromes (1999) (2022)

The SAMBA II POC NATs showed high sensitivity, specificity, and concordance with the gold standard assay, indicating its potential use in diagnostics and monitoring. Future work will evaluate POC NAT implementation in the US.

Keyphrases

nucleic acid
antiretroviral therapy
hiv positive
hiv infected
human immunodeficiency virus
primary care
healthcare
hepatitis c virus
hiv testing
hiv aids
high throughput
current status
quality improvement
south africa
single cell